title: Dual antiplatelet therapy after drug-eluting stent implantation: when is "enough" enough?
authors.affiliation: *Division of Cardiology, Department of Internal Medicine, University of Turin, Turin, Italy; †Interventional Cardiology Unit, Hospital Clinico San Carlos, Madrid, Spain; ‡Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; and §Virginia Commonwealth University, Pauley Heart Center, Medical College of Virginia Campus, Richmond, VA.
authors.forename: Enrico
authors.initials: E
authors.lastname: Cerrato
authors.forename: Fabrizio
authors.initials: F
authors.lastname: DʼAscenzo
authors.forename: Giuseppe G
authors.initials: GG
authors.lastname: Biondi-Zoccai
authors.forename: Antonio
authors.initials: A
authors.lastname: Abbate
mesh_terms: D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D010975:Platelet Aggregation Inhibitors